A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn) (vol 33, pg 1640, 2005)

被引：0
|
作者：
Ferl, Gregory Z. [1 ]
Wu, Anna M. [2 ]
DiStefano, Joseph J., III [3 ,4 ,5 ]
机构：
[1] Genentech Early Dev PKPD, San Francisco, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Biocybernet Lab, Dept Comp Sci, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Biomed Engn, Interdepartmental Program, Los Angeles, CA 90095 USA
来源：
ANNALS OF BIOMEDICAL ENGINEERING | 2011年 / 39卷 / 10期
关键词：
D O I：
10.1007/s10439-011-0373-7
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：2668 / 2668
页数：1
相关论文
共 18 条
  • [1] A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn)
    Gregory Z. Ferl
    Anna M. Wu
    Joseph J. DiStefano
    Annals of Biomedical Engineering, 2005, 33 : 1640 - 1652
  • [2] A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal fc receptor (FcRn)
    Ferl, GZ
    Wu, AM
    DiStefano, JJ
    ANNALS OF BIOMEDICAL ENGINEERING, 2005, 33 (11) : 1640 - 1652
  • [3] Erratum to: A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn)
    Gregory Z. Ferl
    Anna M. Wu
    Joseph J. DiStefano
    Annals of Biomedical Engineering, 2011, 39 : 2668 - 2668
  • [4] Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering
    Wang, Yuan
    Tian, Zehua
    Thirumalai, Diraviyam
    Zhang, Xiaoying
    JOURNAL OF DRUG TARGETING, 2014, 22 (04) : 269 - 278
  • [5] Hypogammaglobulinemia Following Use of An Anti-neonatal Fc Receptor (FcRn) Monoclonal Antibody, Efgartigimod
    Yang, Nancy
    Zhou, Baijun
    Hong, Joseph
    Barmettler, Sara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB28 - AB28
  • [6] Expression of the Neonatal Fc Receptor FcRn Is Not Required for the Amelioration of Murine ITP by IVIg or a Monoclonal Antibody.
    Crow, Andrew R.
    Suppa, Sara J.
    Lazarus, Alan H.
    BLOOD, 2010, 116 (21) : 1048 - 1048
  • [7] The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia
    Crow, Andrew R.
    Suppa, Sara J.
    Chen, Xi
    Mott, Patrick J.
    Lazarus, Alan H.
    BLOOD, 2011, 118 (24) : 6403 - 6406
  • [8] A Minimal Physiologically-Based Pharmacokinetic Model Demonstrates Role of the Neonatal Fc Receptor (FcRn) Competition in Drug-Disease Interactions With Antibody Therapy
    Abdallah, Hussein M.
    Zhu, Andy Z. X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (02) : 423 - 434
  • [9] Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant/β2-microglobulin gene (vol 103, pg 5084, 2006
    Wani, Manzoor A.
    Haynes, Lynn D.
    Kim, Jonghan
    Bronson, C. L.
    Chaudhury, Chaity
    Mohanty, Sudhasri
    Waldmann, Thomas A.
    Robinson, John M.
    Anderson, Clark L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (27) : 10526 - 10526
  • [10] The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma (vol 43, pg 33, 2005)
    Bergón, E
    Miravalles, E
    Bergón, E
    Miranda, I
    Bergón, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (03) : 349 - 349
12